Home > Insider Trading > Novelion Therapeutics Inc. > Profile

Novelion Therapeutics Inc. (NVLN)

Market is closed

Sector: Pharmaceutical Preparations

Related Insiders

Kevin Kotler, Large Shareholder, 2020-01-15
Broadfin Capital, Llc, Large Shareholder, 2020-01-15
Ltd Fund Master Healthcare Broadfin, Large Shareholder, 2020-01-15

Kevin Kotler, Large Shareholder, 2020-01-15
Broadfin Capital, Llc, Large Shareholder, 2020-01-15
Ltd Fund Master Healthcare Broadfin, Large Shareholder, 2020-01-15
Stonepine Capital, L.p., Large Shareholder, 2019-12-12
Dennis Michael Price, Chief Financial Officer, 2019-09-26
Y Barbara Chan, See Remarks, 2019-09-26
Roger Louis, See Remarks, 2019-05-13
Linda Buono, Sr. Vp, Human Resources, 2019-05-13
Benjamin Harshbarger, See Remarks, 2019-05-13
Jeffrey Hackman, C.o.o. And Interim C.e.o., 2018-11-05
Mark Dipaolo, Director, 2018-08-13
J John Orloff, Director, 2018-08-13
L Stephen Sabba, Director, 2018-08-13
Louise Suzanne Bruhn, Director, 2018-08-13
K Donald Stern, Director, 2018-08-13
C John Thomas, Director, 2018-08-13
Mark Corrigan, Director, 2018-08-13
Murray Stewart, Executive Vice President, R&D, 2018-02-14
Jason Aryeh, Director, 2017-05-17
T Mary Szela, Chief Executive Officer, 2017-05-11
D Gregory Perry, See Remarks, 2017-05-11
D Sandford Smith, Director, 2017-02-03
F Geoffrey Cox, Director, 2016-12-27
Anne Vanlent, Director, 2016-12-27
Md Jorge Plutzky, Director, 2016-12-27
A Remi Menes, See Remarks, 2016-12-27
Aegerion Pharmaceuticals, Inc., Large Shareholder, 2016-06-24
Glen William Ibbott, Svp, Finance & Cfo, 2016-06-22
Christine Dori Assaly, Svp, Legal & Corp. Secy., 2016-06-22
A Jeffrey Meckler, Director, 2016-06-22
W John Kozarich, Director, 2016-06-22
Elizabeth Lana Janes, Sr. Vice Pres. - See Remarks, 2016-06-22
Marc Andersen, Large Shareholder, 2015-06-17
Assouline, Eliav, Large Shareholder, 2015-06-17
Axial Capital Management, Llc, Large Shareholder, 2015-06-17
Axial Capital Master, L.p., Large Shareholder, 2015-06-17
K/S Equity Public Nb, Large Shareholder, 2014-07-15
Florian Schonharting, Large Shareholder, 2014-07-15
Auxilium Pharmaceuticals Inc, Large Shareholder, 2014-07-07
R Alexander Lussow, Sr. Vp, Bus. Dev. & Comm. Op., 2013-11-25
Jr Vicente Anido, Director, 2013-07-17
Sukhi Jagpal, Chief Financial Officer, 2013-07-17
Linda Lupini, Senior Vp, Hr & Org. Dev., 2012-08-15
Cormatrix Cardiovascular Inc, Director, 2012-07-13
Boyd C Clarke, Other, 2012-07-11
A. Christopher Muller, See Remarks, 2012-04-17
Robert Butchofsky, President And Ceo, 2012-03-22
Suzanne Cadden, Svp, Development, 2011-09-21
Cora Madsen, Large Shareholder, 2011-09-01
Christian Hansen, Large Shareholder, 2011-08-31
A Peter Crossgrove, Director, 2011-05-28
E Kathryn Falberg, Director, 2011-05-28
Cameron Nelson, Senior Vp, Finance And Cfo, 2011-05-28
J Ian Massey, Director, 2011-05-28
A L Bruce Carter, Director, 2011-05-28
L Joseph Turner, Director, 2011-05-28
Jack Wood, Director, 2011-05-28
Dipak Panigrahi, Svp, R&D And Cmo, 2010-05-25
Simons James H Renaissance Technologies Llc, Other, 2009-03-17
Yong Hao, Officer, 2009-03-13

Show All Insiders (60)

Hedge Fund Popularity

Display

Display Share Price

Display Standard Version

Hedge Fund Holdings

Filing Period:

Last updated on May 13, 2020, 2:41 pm based on SEC 13F filings Last update: May 13, 2020, 2:41 pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Stonepine Capital Timothy P. Lynch	0	$0		0%
2.	Dorset Management David M. Knott	0	$0		0%

Insider Trading: Purchases See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Stonepine	$0.70	1,000	Large Shareholder	3,909,207	2019-12-12	Filing
Stonepine	$0.69	40	Large Shareholder	3,908,207	2019-12-11	Filing
Stonepine	$0.69	5,202	Large Shareholder	3,908,167	2019-12-10	Filing
Stonepine	$0.70	4,500	Large Shareholder	3,902,965	2019-12-09	Filing
Stonepine	$0.70	40	Large Shareholder	3,898,465	2019-12-06	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Relationship	Remaining Holdings	Date	Form 4
Broadfin	$0.85	100,000	Large Shareholder	1,498,553	2018-12-27	Filing
Broadfin	$0.85	56,316	Large Shareholder	1,598,553	2018-12-27	Filing
Broadfin	$0.88	14,800	Large Shareholder	1,654,869	2018-12-27	Filing
Broadfin	$0.91	30,726	Large Shareholder	1,669,669	2018-12-26	Filing
Broadfin	$0.91	28,745	Large Shareholder	1,700,395	2018-12-26	Filing